Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,906,673
+$1,497,341 QoQ
Shares Held
881,323
+5.4% QoQ
Ownership
0.076%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026VAN ECK ASSOCIATES CORP holds $679,878,666 across 12 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,948,745 | $466,781,145 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,664,458 | $50,133,474 | |
| 3 | HLN |
Haleon plc
|
4,639,437 | $46,440,764 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,260,104 | $41,857,126 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
931,364 | $22,287,540 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
34,287 | $20,331,504 | |
| 7 | VTRS |
Viatris Inc
This page
|
881,323 | $11,906,673 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
89,059 | $11,732,631 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,906,673 | 881,323 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,409,332 | 836,091 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,902,698 | 394,212 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,504,523 | 504,426 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,320,153 | 1,873,726 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,593,037 | 1,011,489 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $13,591,013 | 1,170,630 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $10,783,379 | 1,014,429 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $11,548,068 | 967,175 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $13,530,676 | 1,249,370 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $17,003,953 | 1,724,539 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $17,776,395 | 1,781,202 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $11,945,788 | 1,241,766 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $25,575,681 | 2,297,905 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $17,019,227 | 1,997,562 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $24,051,390 | 2,297,172 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $17,168,607 | 1,577,997 | Shares | Defined | 2022-05-10 | |
| 2021-12-31 | $17,525,827 | 1,295,331 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $14,038,422 | 1,036,046 | Shares | Defined | 2021-11-03 | |
| 2021-06-30 | $9,894,452 | 692,404 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $10,382,098 | 743,171 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $12,157,331 | 648,737 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||